{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: In blocking the positive inotropic and chronotropic responses to isoprenaline , ( + ) - propranolol had less than one hundredth the potency of ( - ) - propranolol .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| None identified in the paragraph |\n\nThe paragraph is discussing the pharmacological properties of two enantiomers (isomers with the same molecular formula but different three-dimensional structures) of propranolol, specifically their effects on the heart's positive inotropic and chronotropic responses to isoprenaline. It does not mention any specific diseases."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| None identified in the paragraph |\n\nThe paragraph is discussing the pharmacological properties of two enantiomers (isomers with the same molecular formula but different three-dimensional structures) of propranolol and their effects on the heart's positive inotropic and chronotropic responses to isoprenaline. It does not mention any specific diseases."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: In blocking the positive inotropic and chronotropic responses to isoprenaline , ( + ) - propranolol had less than one hundredth the potency of ( - ) - propranolol .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| ( + ) - propranolol |\n| ( - ) - propranolol |\n| isoprenaline |\n\nIn this paragraph, the entities are the named chemicals: ( + ) - propranolol, ( - ) - propranolol, and isoprenaline."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| ( + ) - propranolol |\n| ( - ) - propranolol |\n| isoprenaline |\n\nThe entities in the paragraph are clearly identified as chemicals, as they are named compounds."}
  ]
}